Characterization of the heparin-binding properties of IL-6.

scientific article

Characterization of the heparin-binding properties of IL-6. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4049/JIMMUNOL.165.10.5671
P698PubMed publication ID11067924
P5875ResearchGate publication ID12259537

P2093author name stringRider CC
Mummery RS
P433issue10
P407language of work or nameEnglishQ1860
P304page(s)5671-5679
P577publication date2000-11-01
P1433published inJournal of ImmunologyQ3521441
P1476titleCharacterization of the heparin-binding properties of IL-6.
P478volume165

Reverse relations

cites work (P2860)
Q388861144-methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis
Q36053859A Modified Glycosaminoglycan, GM-0111, Inhibits Molecular Signaling Involved in Periodontitis
Q40680425A role for chondroitin sulphate B in the activity of interleukin 12 in stimulating gamma-interferon secretion
Q78311333Abundance of interstitial heparan sulfate in granuloma annulare but not in other mucinous skin diseases
Q78596892Adsorption of inflammatory cytokines using a heparin-coated extracorporeal circuit
Q41908191Affinity-based microdialysis sampling using heparin for in vitro collection of human cytokines
Q94466952Anticoagulation in COVID-19
Q46576624Antithrombotic agents in the treatment of severe sepsis
Q44321221Avidin is a heparin-binding protein. Affinity, specificity and structural analysis
Q35629808Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease
Q37216313Biological implications of glycosaminoglycan interactions with haemopoietic cytokines.
Q47927555CD138 mediates selection of mature plasma cells by regulating their survival
Q42136802Cell Penetrating Peptide Derived from Human Eosinophil Cationic Protein Decreases Airway Allergic Inflammation
Q99636156Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system
Q51262503Collageneous matrix coatings on titanium implants modified with decorin and chondroitin sulfate: characterization and influence on osteoblastic cells.
Q80801016Effect of biological implant surface coatings on bone formation, applying collagen, proteoglycans, glycosaminoglycans and growth factors
Q28655742Efficient production and purification of recombinant human interleukin-12 (IL-12) overexpressed in mammalian cells without affinity tag
Q36194659Extracellular matrix in bone marrow can mediate drug resistance in myeloma
Q42765133Extracellular matrix-associated cytokines regulate CD4+ effector T-cell responses in the human intestinal mucosa.
Q38784876Function of Membrane-Associated Proteoglycans in the Regulation of Satellite Cell Growth
Q40803938Glycosaminoglycan binding properties of the myxoma virus CC-chemokine inhibitor, M-T1.
Q36545260HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer
Q50859715Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells.
Q38312824Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma
Q36736317Heparin and structurally related polymers attenuate eotaxin-1 (CCL11) release from human airway smooth muscle.
Q92152542Heparinoid Complex-Based Heparin-Binding Cytokines and Cell Delivery Carriers
Q40655653Hyaluronan, a major non‐protein glycosaminoglycan component of the extracellular matrix in human bone marrow, mediates dexamethasone resistance in multiple myeloma
Q43559228Hyaluronic acid induces survival and proliferation of human myeloma cells through an interleukin-6-mediated pathway involving the phosphorylation of retinoblastoma protein
Q37101083Hyperglycemia induces altered expressions of angiogenesis associated molecules in the trophoblast
Q40161562Impact of heparin and short term anesthesia on the quantification of cytokines in laboratory mouse plasma.
Q51062152Influence of extracellular matrix coatings on implant stability and osseointegration: an animal study.
Q28216986Influence of low molecular weight heparin (certoparin) and unfractionated heparin on the release of cytokines from human leukocytes
Q94337757Interstitial heparan sulfate in granulomatous inflammatory skin diseases
Q33903041Modulation of Interleukin-12 activity in the presence of heparin
Q50933362On-demand dissolution of modular, synthetic extracellular matrix reveals local epithelial-stromal communication networks.
Q33675726Ovarian cancer cell heparan sulfate 6-O-sulfotransferases regulate an angiogenic program induced by heparin-binding epidermal growth factor (EGF)-like growth factor/EGF receptor signaling
Q40044234Perlecan: a major IL-2-binding proteoglycan in murine spleen
Q44746095Regulation of interleukin-6 fetoplacental levels could be involved in the protective effect of low-molecular weight heparin treatment on murine spontaneous abortion
Q35690362Solid phase assays in glycoconjugate research: applications to the analysis of proteoglycans, glycosaminoglycans and metalloproteinases
Q46595777Spatiotemporal expression of chondroitin sulfate sulfotransferases in the postnatal developing mouse cerebellum
Q35186646Stromal regulation of human gastric dendritic cells restricts the Th1 response to Helicobacter pylori
Q40677051Syndecan captures, protects, and transmits HIV to T lymphocytes
Q36761832Syndecan-1 is an in vivo suppressor of Gram-positive toxic shock
Q39216398Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation
Q37346515The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance
Q99711257The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review
Q58794936The localisation of the heparin binding sites of human and murine interleukin-12 within the carboxyterminal domain of the P40 subunit
Q95264258Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes

Search more.